BOSTON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders (CervoMed or the Company), today ...
Dementia is a challenging condition affecting millions of individuals and their families. Understanding the legal ramifications surrounding dementia patients, p ...